The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Verhagen, A
Shirango, H
Thunnissen, E
Tjan-Heijnen, V
van der Drift, M
van der Bruggen, W
Bulten, H
机构：
[1] Radboud Univ, Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp Nijmegen, Nijmegen, Netherlands
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80882-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [31] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [32] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [33] Surgery in patients with non-small cell lung cancer (NSCLC):: An analysis of 133 patients
    Skricková, J
    Babicková, L
    Kaplanová, J
    Kubová, O
    Pálková, I
    Tomísková, M
    Svobodník, A
    Spelda, S
    Koptíková, J
    Merta, Z
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 169 - 173
  • [34] Advances in lymphatic metastasis of non-small cell lung cancer
    Zhang, Xiaofei
    Ma, Li
    Xue, Man
    Sun, Yanning
    Wang, Zhaoxia
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [35] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN MEXICO
    Flores-Caballero, M. A.
    Lugo-Martinez, G.
    Rodriguez-Cid, J. R.
    Juarez-Vignon Whaley, J.
    Martinez-Herrera, J. F.
    Cruz-Zermeno, M.
    Seidman-Sorsby, A.
    Garcia-Montes, V
    Garibay-Diaz, J. C.
    Gonzalez Espinosa, I
    Hernandez-Flores, O.
    Oyervides-Juarez, V. M.
    Lopez Lopez, F.
    Gonzalez-Cisneros, P.
    Riera Sala, R.
    Alatorre-Alexander, J.
    Dorokhova, E.
    Betancur, M. A.
    Medina, S.
    Flores-Garcia, L.
    Amaya-Gutierrez, M. J.
    Rodriguez-Rosales, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S238 - S238
  • [36] Clinical validation and utility of InVision ctDNA in advanced non-small cell lung cancer (NSCLC) patients
    Remon, J.
    Mezquita, L.
    Planchard, D.
    Jovelet, C.
    Lacroix, L.
    Rouleau, E.
    Howarth, K.
    Plagnol, V.
    Morris, C.
    Green, E.
    Le Pechoux, C.
    Caramella, C.
    Adam, J.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Advances in lymphatic metastasis of non-small cell lung cancer
    Xiaofei Zhang
    Li Ma
    Man Xue
    Yanning Sun
    Zhaoxia Wang
    Cell Communication and Signaling, 22
  • [38] Lymphatic extension and lymphangiogenesis in non-small cell Lung cancer
    Cazes, A.
    Gibault, L.
    Rivera, C.
    Mordant, P.
    Riquet, M.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2014, 70 (1-2) : 26 - 31
  • [39] Clinical factors affecting the late resistance to gefitinib in patients with non-small cell lung cancer (NSCLC).
    Segawa, Y.
    Hotta, K.
    Umemura, S.
    Fujiwara, Y.
    Shinkai, T.
    Ueoka, H.
    Takigawa, N.
    Tabata, M.
    Kiura, K.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 411S - 411S
  • [40] Prognosis of Patients With Stages I and II Non-Small Cell Lung Cancer With Nodal Micrometastases
    Gwozdz, Pawel
    Pasieka-Lis, Monika
    Kolodziej, Katarzyna
    Pankowski, Juliusz
    Banas, Renata
    Wilkojc, Michal
    Zielinski, Marcin
    ANNALS OF THORACIC SURGERY, 2018, 105 (05): : 1551 - 1557
12345